Graft versus host disease prophylaxis/therapy

Known as: prophylaxis/therapy, graft versus host disease, prophylaxis/therapy, GVHD, GVHD 
Therapy to prevent or treat graft vs host disease.

Topic mentions per year

Topic mentions per year

1962-2018
020040019622018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
No validated biomarkers exist for acute graft-versus-host disease (GVHD). We screened plasma with antibody microarrays for 120… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Invasive fungal infections are an important cause of morbidity and mortality after allogeneic hematopoietic stem-cell… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Mesenchymal stem cells (MSCs) are multipotent cells found in several adult tissues. Transplanted allogeneic MSCs can be detected… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
It is unknown whether the severity, timing, and quality of graft-versus-host disease (GVHD) may be different after… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality in allogeneic stem cell transplantation… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Toxicities have limited the use of allogeneic hematopoietic cell transplantation (HCT) to younger, medically fit patients. In a… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Myeloablative conditioning associated with hazardous immediate and late complications is considered as a mandatory first step in… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
We report the results of a phase III open-label, randomized, multicenter trial comparing tacrolimus/methotrexate to cyclosporine… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The immune-mediated graft-versus-leukemia effect is important to prevent relapse after allogeneic progenitor cell transplantation… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Acute graft-versus-host disease (GVHD) severity is graded by pattern of organ involvement and clinical performance status using a… (More)
  • table I
  • table II
  • table III
  • table IV
  • table V
Is this relevant?